Business Description
Spectral Medical Inc
NAICS : 334512
SIC : 8683
ISIN : CA8475771033
Total Employee Number:
29Description
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. Its products include an endotoxin activity assay, a rapid in-vitro diagnostic test used to measure endotoxin levels in blood, and a polymyxin B hemoperfusion device designed to remove endotoxin from the bloodstream. The company's proprietary reagents include recombinant proteins, antibodies, and calibrators used in research and diagnostic applications.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | -15.46 | |||||
Debt-to-Equity | -0.33 | |||||
Debt-to-EBITDA | -0.72 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -94.29 | |||||
Beneish M-Score | 19.08 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.5 | |||||
3-Year EBITDA Growth Rate | -94.4 | |||||
3-Year EPS without NRI Growth Rate | -6.5 | |||||
3-Year FCF Growth Rate | 2.8 | |||||
3-Year Book Growth Rate | -197.9 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 169.74 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 60.84 | |||||
9-Day RSI | 54.39 | |||||
14-Day RSI | 50.49 | |||||
3-1 Month Momentum % | -0.6 | |||||
6-1 Month Momentum % | -6.7 | |||||
12-1 Month Momentum % | 60.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.06 | |||||
Quick Ratio | 0.05 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 82.88 | |||||
Days Sales Outstanding | 45.79 | |||||
Days Payable | 836.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.6 | |||||
Shareholder Yield % | -1.67 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 51.58 | |||||
Operating Margin % | -393.01 | |||||
Net Margin % | -1377.18 | |||||
EBITDA Margin % | -1162.15 | |||||
FCF Margin % | -378.32 | |||||
OCF Margin % | -378.32 | |||||
ROA % | -670.38 | |||||
ROIC % | -20.66 | |||||
3-Year ROIIC % | -10.12 | |||||
ROC (Joel Greenblatt) % | -6143.62 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio without NRI | 31.06 | |||||
PS Ratio | 151.84 | |||||
EV-to-EBIT | -12.99 | |||||
EV-to-EBITDA | -13.09 | |||||
EV-to-Revenue | 152.15 | |||||
EV-to-Forward-Revenue | 53.89 | |||||
EV-to-FCF | -39.82 | |||||
Price-to-GF-Value | 1.47 | |||||
Price-to-Median-PS-Value | 3.06 | |||||
Earnings Yield (Greenblatt) % | -7.7 | |||||
FCF Yield % | -2.62 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Spectral Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.73 | ||
| EPS (TTM) (€) | -0.074 | ||
| Beta | 0.2277 | ||
| 3-Year Sharpe Ratio | 0.9 | ||
| 3-Year Sortino Ratio | 2.66 | ||
| Volatility % | 80.26 | ||
| 14-Day RSI | 50.49 | ||
| 14-Day ATR (€) | 0.020408 | ||
| 20-Day SMA (€) | 0.818 | ||
| 12-1 Month Momentum % | 60.58 | ||
| 52-Week Range (€) | 0.472 - 1.07 | ||
| Shares Outstanding (Mil) | 293.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Spectral Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Spectral Medical Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Spectral Medical Inc Frequently Asked Questions
What is Spectral Medical Inc(STU:SD4)'s stock price today?
The current price of STU:SD4 is €0.83. The 52 week high of STU:SD4 is €1.07 and 52 week low is €0.47.
When is next earnings date of Spectral Medical Inc(STU:SD4)?
The next earnings date of Spectral Medical Inc(STU:SD4) is .
Does Spectral Medical Inc(STU:SD4) pay dividends? If so, how much?
Spectral Medical Inc(STU:SD4) does not pay dividend.
Press Release
Articles on Spectral Medical Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers